Henry Schein (NASDAQ:HSIC) Hits New 12-Month High – What’s Next?

Henry Schein, Inc. (NASDAQ:HSIC)’s share price reached a new 52-week high during trading on Thursday . The company traded as high as $89.34 and last traded at $88.8640, with a volume of 17165 shares. The stock had previously closed at $87.16.

Analysts Set New Price Targets

A number of research firms have weighed in on HSIC. Mizuho decreased their target price on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. UBS Group restated a “neutral” rating and issued a $85.00 price target (down from $87.00) on shares of Henry Schein in a research report on Wednesday, May 6th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Henry Schein in a research note on Monday, May 4th. BTIG Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Thursday, June 11th. Finally, Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Sunday. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Henry Schein has a consensus rating of “Hold” and a consensus target price of $87.64.

Henry Schein Stock Performance

The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.75 and a current ratio of 1.36. The company has a 50 day moving average price of $78.81 and a 200 day moving average price of $77.56. The company has a market capitalization of $10.12 billion, a price-to-earnings ratio of 26.88, a P/E/G ratio of 1.67 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.12. The business had revenue of $3.37 billion for the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.15 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities research analysts predict that Henry Schein, Inc. will post 5.32 earnings per share for the current fiscal year.

Insider Transactions at Henry Schein

In other Henry Schein news, Director William K. Daniel purchased 10,000 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was acquired at an average price of $69.19 per share, for a total transaction of $691,900.00. Following the purchase, the director owned 20,000 shares of the company’s stock, valued at $1,383,800. This trade represents a 100.00% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.89% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of HSIC. Ameriprise Financial Inc. raised its stake in shares of Henry Schein by 3,275.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company’s stock worth $165,594,000 after purchasing an additional 2,199,695 shares during the period. Bank of Montreal Can grew its position in Henry Schein by 3,655.7% during the fourth quarter. Bank of Montreal Can now owns 2,144,773 shares of the company’s stock valued at $162,102,000 after buying an additional 2,087,666 shares during the period. Norges Bank bought a new position in Henry Schein during the fourth quarter valued at about $88,116,000. Southpoint Capital Advisors LP increased its holdings in Henry Schein by 28.0% during the first quarter. Southpoint Capital Advisors LP now owns 3,200,000 shares of the company’s stock worth $235,840,000 after buying an additional 700,000 shares during the last quarter. Finally, Bank of America Corp DE increased its holdings in Henry Schein by 204.2% during the second quarter. Bank of America Corp DE now owns 995,375 shares of the company’s stock worth $72,712,000 after buying an additional 668,182 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.